lilly to acquire global license to axiron, page-23

  1. 509 Posts.
    $44n mil profit. 160 mil shares = PER around 8-9. That's fairly cheap.
    But if you're in for the long haul Axiron is the first step. There are numerous more drugs that can be licensed etc to be delivered by Acrux technology. Patches may become obsolete. It can be an option where tablets aren't suitable. If you're prepared to wait there can be big upside here or still takeover.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $6.524M
Open High Low Value Volume
1.5¢ 1.6¢ 1.5¢ $9.887K 624.5K

Buyers (Bids)

No. Vol. Price($)
1 6355 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 20000 1
View Market Depth
Last trade - 15.00pm 26/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.